A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol-Reference-Cited by-同舟云学术

A multicenter, randomized, placebo-controlled trial for cilostazol in patients with mild cognitive impairment: The COMCID study protocol

Published:2016-10-27 Issue:4 Volume:2 Page:250-257
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Saito Satoshi¹²,Kojima Shinsuke³,Oishi Naoya⁴⁵,Kakuta Ryosuke⁶,Maki Takakuni²,Yasuno Fumihiko⁷,Nagatsuka Kazuyuki⁶,Yamamoto Haruko⁸,Fukuyama Hidenao⁴⁵,Fukushima Masanori³,Ihara Masafumi¹⁶

Affiliation:

1. Department of Regenerative Medicine and Tissue Engineering; National Cerebral and Cardiovascular Center; Suita Japan

2. Department of Neurology; Kyoto University Graduate School of Medicine; Kyoto Japan

3. Department of MediScience; Translational Research Informatics Center, Foundation for Biomedical Research and Innovation; Kobe Japan

4. Human Brain Research Center, Kyoto University Graduate School of Medicine; Kyoto Japan

5. Center for the Promotion of Interdisciplinary Education and Research, Kyoto University; Kyoto Japan

6. Department of Stroke and Cerebrovascular Diseases; National Cerebral and Cardiovascular Center; Suita Japan

7. Department of Psychiatry; Nara Medical University; Kashihara Japan

8. Center for Advancing Clinical and Translational Sciences, National Cerebral and Cardiovascular Center; Suita Japan

Funder

Otsuka Pharmaceutical Company

Intramural Research Fund

Publisher

Wiley

Subject

Psychiatry and Mental health,Clinical Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.trci.2016.10.001/fullpdf

Reference31 articles.

1. New insights into the dementia epidemic;Larson;N Engl J Med,2013

2. Clearance systems in the brain-implications for Alzheimer disease;Tarasoff-Conway;Nat Rev Neurol,2015

3. Impaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's disease;Gupta;Front Aging Neurosci,2015

4. Interaction between cerebrovascular disease and Alzheimer pathology;Saito;Curr Opin Psychiatry,2016

5. Decreased clearance of CNS β-amyloid in Alzheimer's disease;Mawuenyega;Science,2010

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is cerebral small vessel disease a central nervous system interstitial fluidopathy?;IBRO Neuroscience Reports;2024-06

2. Tetrazole derivatives in the management of neurological disorders: Recent advances on synthesis and pharmacological aspects;European Journal of Medicinal Chemistry;2024-05

3. Platelet Dynamics in Neurodegenerative Disorders: Investigating the Role of Platelets in Neurological Pathology;Journal of Clinical Medicine;2024-04-03

4. Efficacy and Safety of Cilostazol in Mild Cognitive Impairment;JAMA Network Open;2023-12-04

5. Amyloid-β: A potential mediator of aging-related vascular pathologies;Vascular Pharmacology;2023-10